| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB6302A | |||
| Carrier Free | MAB6302-SP | |||
| Carrier Free | FAB6302V-100UG | |||
| Carrier Free | FAB6302U-100UG | |||
| Carrier Free | FAB6302T-100UG | |||
| Carrier Free | FAB6302S-100UG | |||
| Carrier Free | FAB6302R-100UG | |||
| Carrier Free | FAB6302N-100UG | |||
| Carrier Free | FAB6302G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF630-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB6301-SP | |||
| Carrier Free | MAB6301-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76881SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB630-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14580-500ul | |||
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0002.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.")
![Immunocytochemistry/Immunofluorescence: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa cells with DcR1 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76881-img0006.jpg)
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa whole cell lysate with TRAIL-R3 antibody (ED) at 1:500 dilution.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Immunofluorescence of DcR1 in Hela cells with DcR1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76881-img0005.jpg)
![Western Blot: TRAIL R3/TNFRSF10C Antibody [NB100-56445] - Analysis of TRAIL R3/TNFRSF10C 15 ug of mouse spleen cell lysate using this antibody.](http://images.novusbio.com/fullsize/TRAIL-R3-TNFRSF10C-Antibody-Western-Blot-NB100-56445-img0003.jpg "Western Blot: TRAIL R3/TNFRSF10C Antibody [NB100-56445] - Analysis of TRAIL R3/TNFRSF10C 15 ug of mouse spleen cell lysate using this antibody.")
![Western Blot: TRAILR3/TNFRSF10C Antibody (JE58-51) [NBP3-32257] - Western blot analysis of TRAILR3/TNFRSF10C on different lysates with Rabbit anti-TRAILR3/TNFRSF10C antibody (NBP3-32257) at 1/1,000 dilution. Lane 1: JAR cell lysate Lane 2: Jurkat cell lysate Lane 3: A549 cell lysate Lane 4: HeLa cell lysate Lane 5: Raji cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 27 kDa Observed band size: 27/70/80 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32257) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32257_rabbit-trailr3-tnfrsf10c-mab-je58-51-27820241529552.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody (JE58-51) [NBP3-32257] - Western blot analysis of TRAILR3/TNFRSF10C on different lysates with Rabbit anti-TRAILR3/TNFRSF10C antibody (NBP3-32257) at 1/1,000 dilution. Lane 1: JAR cell lysate Lane 2: Jurkat cell lysate Lane 3: A549 cell lysate Lane 4: HeLa cell lysate Lane 5: Raji cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 27 kDa Observed band size: 27/70/80 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32257) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.")
![Immunocytochemistry/ Immunofluorescence: TRAILR3/TNFRSF10C Antibody (JE58-51) [NBP3-32257] - Immunocytochemistry analysis of Jurkat cells labeling TRAILR3/TNFRSF10C with Rabbit anti-TRAILR3/TNFRSF10C antibody (NBP3-32257) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-TRAILR3/TNFRSF10C antibody (NBP3-32257) at 1/100 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (red) was stained at 1/200 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594) was used as the secondary antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/nbp3-32257_rabbit-trailr3-tnfrsf10c-mab-je58-51-2920241114817.jpg)
![Flow Cytometry: TRAILR3/TNFRSF10C Antibody (JE58-51) [NBP3-32257] - Flow cytometric analysis of Jurkat cells labeling TRAILR3/TNFRSF10C. Cells were fixed and permeabilized. Then stained with the primary antibody (NBP3-32257, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp3-32257_rabbit-trailr3-tnfrsf10c-mab-je58-51-29202416372111.jpg)
![Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Negative control.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-TR3-06-Immunohistochemistry-Paraffin-NBP2-80071-img0002.jpg "Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Negative control.")
![Immunohistochemistry-Paraffin: TRAILR3/TNFRSF10C Antibody (TR3.06) [NBP2-80071] - Immunohistochemistry detection of endogenous TRAIL-R3 in paraffin-embedded human carcinoma tissues (colon, tonsil) using mAb to TRAIL-R3 (TR3.06).](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-TR3-06-Immunohistochemistry-Paraffin-NBP2-80071-img0001.jpg)
![Western Blot: TRAILR3/TNFRSF10C Antibody (SR1429) [NBP3-22617] - Western blot analysis using NBP3-22617 in Jurkat cell lysate.](http://images.novusbio.com/fullsize/nbp3-22617_rabbit-trailr3-tnfrsf10c-mab-sr1429-5720231521386.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody (SR1429) [NBP3-22617] - Western blot analysis using NBP3-22617 in Jurkat cell lysate.")
![Flow Cytometry: TRAILR3/TNFRSF10C Antibody (B-D44) [NBP3-14580] - A typical staining pattern with the B-D44 monoclonal antibody of granulocytes.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-B-D44-Flow-Cytometry-NBP3-14580-img0001.jpg "Flow Cytometry: TRAILR3/TNFRSF10C Antibody (B-D44) [NBP3-14580] - A typical staining pattern with the B-D44 monoclonal antibody of granulocytes.")
![Flow Cytometry: TRAILR3/TNFRSF10C Antibody (003) [NBP2-89484] - Analysis of Human TNFRSF10C(CD263) expression on human whole blood granulocytes. Cells were stained with purified anti-Human TNFRSF10C(CD263), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-003-Flow-Cytometry-NBP2-89484-img0001.jpg "Flow Cytometry: TRAILR3/TNFRSF10C Antibody (003) [NBP2-89484] - Analysis of Human TNFRSF10C(CD263) expression on human whole blood granulocytes. Cells were stained with purified anti-Human TNFRSF10C(CD263), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.")